ELEM Biotech Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
ELEM Biotech General Information
Description
Developer of high-throughput cell editing tools designed for drug discovery and basic research. The company offers gene-edited cells, knockout kits, arrayed gene perturbation libraries, and customized gene editing services, thereby providing pharmaceutical companies and research institutions with specialized hardware and datasets for genomic validation and virtual cell modeling.
Contact Information
Website
www.elem-bio.cn(Operating Subsidiary)
Corporate Office
- Room 201, 2nd Floor & 402, 4th Floor, Building 9, Wuhan Bio-Agricultural Industry Base
- Number 8 Jiulong South Road, East Lake High-tech Development Zone
- Wuhan, Hubei
- China
Corporate Office
- Room 201, 2nd Floor & 402, 4th Floor, Building 9, Wuhan Bio-Agricultural Industry Base
- Number 8 Jiulong South Road, East Lake High-tech Development Zone
- Wuhan, Hubei
- China
ELEM Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ELEM Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ELEM Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ELEM Biotech Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ELEM Biotech FAQs
-
When was ELEM Biotech founded?
ELEM Biotech was founded in 2018.
-
Where is ELEM Biotech headquartered?
ELEM Biotech is headquartered in Wuhan, China.
-
What is the size of ELEM Biotech?
ELEM Biotech has 5 total employees.
-
What industry is ELEM Biotech in?
ELEM Biotech’s primary industry is Discovery Tools (Healthcare).
-
Is ELEM Biotech a private or public company?
ELEM Biotech is a Private company.
-
What is ELEM Biotech’s current revenue?
The current revenue for ELEM Biotech is .
-
Who are ELEM Biotech’s investors?
Hangke Kehuazhang Private Equity, Highlight Capital, Jiangsu Shiyuan Private Equity Fund Management, and Xinghua Dingli Capital have invested in ELEM Biotech.
-
When was ELEM Biotech acquired?
ELEM Biotech was acquired on 29-Oct-2026.
-
Who acquired ELEM Biotech?
ELEM Biotech was acquired by Pet Pharm Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
